During a retroactive review of past complaints for potential adverse events, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.A (b)(6) year old male patient received a treatment on (b)(6) 2012 and later reported that he suffered a wrist fracture.The patient was walking at the time of the treatment.An arrhythmia was detected at 13:44:06.A 150j pulse was delivered at 13:44:50.The post-shock rhythm was dual-lead signal artifact with an underlying normal sinus rhythm.Dual-lead signal artifact contributed to the false detection.The patient reported that he pressed the response buttons but was still treated.A review of device flag data shows that the response buttons were used intermittently during the event but not directly prior to the defibrillation.The device was shutdown at 13:46:06.The patient reported falling to the ground after the treatment was delivered and fractured his wrist.On (b)(6) 2014, a zoll service representative visited the patient after the treatment, and the patient did not report any injury to his wrist at that time.On (b)(6) 2012, the patient contacted zoll to report that he had gone to the hospital and received a cast for his broken wrist.The patient continued to use the lifevest.
|
Device evaluation summary: device evaluation of monitor sn (b)(4) and electrode belt sn (b)(4) was completed.The monitor and electrode belt were fully functional upon receipt.There was no device malfunction.Monitor: sn (b)(4), manufactured (b)(6) 2010; electrode belt: sn (b)(4), manufactured (b)(6) 2010.
|